It is esIt is our pleasure to invite you to participate in The 3rd World Congress on Clinical Trials in Diabetes (WCTD2018), which will take place 3-4 December 2018 in Vienna, Austria.
WCTD2018 follows the success of the 2nd Congress held in Berlin in 2017 and will continue to address the multitude of complex issues associated with clinical trials in diabetes.
It is clear that there is a continuing necessity to streamline these issues into a process that will improve drug development in terms of approval and commercialization, and address the various aspects of drug and device development and the way to enhance them.
Once again, our world renowned faculty will tackle issues head on through a comprehensive program which will focus on key areas including:
Design the Best Study
Improve Regulatory Process
Better Understanding of How to Collaborate with Regulatory Authorities
Involvement of Digital Medicine
Management of Diabetes and Personalized Medicine
The scientific program will have a broad therapeutic focus and tackle both the global and specific regional differences. The program will include speakers such as physicians, R&D personnel, regulatory decision makers, CEOs, CROs, CRAs, Clinical Trial Managers and QA personnel.
You are invited and encouraged to contribute to the program by submitting abstracts for oral and poster presentation and we look forward to your active involvement.
We look forward to seeing you at WCTD2018 in the exciting and historical city of Vienna, which provides an unforgettable backdrop for the Congress.
Prof. Philip Home Bioevents
Congress Chair Congress Organizerential to inform this description this is your personal promotion for this event and for its referencing.